Feb 20, 2024 9:31am EST FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
Feb 13, 2024 9:31am EST FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
Feb 08, 2024 9:31am EST FibroBiologics Announces Three United States Patents for Fibroblast Technology
Jan 31, 2024 10:00am EST FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG